OwlTail

Cover image of Robin Feldman

Robin Feldman

6 Podcast Episodes

Latest 18 Sep 2021 | Updated Daily

Weekly hand curated podcast episodes for learning

Episode artwork

HOW YOU CAN PROTECT YOURSELF AGAINST MEDICAL BANKRUPTCY—Robert & Kim Kiyosaki featuring Robin Feldman

Rich Dad Radio Show: In-Your-Face Advice on Investing, Personal Finance, & Starting a Business

The leading cause of bankruptcy in the U.S. is from medical costs. Big Pharma is front-and-center to this problem. Robin Feldman joins Robert & Kim to discuss her research into how Big Pharma oftentimes secretly works to keep drug prices high and thwart free-market competition. Find out why U.S. citizens subsidize drug prices around the world. Robin offers tips on how you can protect yourself from medical bankruptcy. Learn more about your ad choices. Visit megaphone.fm/adchoices

43mins

12 Jun 2019

Episode artwork

8: Drug Pricing in the United States: a Conversation with Robin Feldman

Not So Different: a Podcast from The Center for Biosimilars

Recent months have seen a variety of proposals to bring down the cost of prescription drugs, but will any of them have staying power? This week, senior editor Allison Inserro speaks with Robin Feldman, professor at the University of California, Hastings, College of the Law, and author of the new book Drugs, Money, and Secret Handshakes: The Unstoppable Growth of Prescription Drug Prices.

22mins

14 Apr 2019

Similar People

Episode artwork

Robin Feldman on Drugs, Money, and Secret Handshakes

EconTalk

Law professor and author Robin Feldman of UC Hastings College of the Law talks about her book Drugs, Money, and Secret Handshakes with EconTalk host Russ Roberts. Feldman argues that the legal and regulatory environment for drug companies encourages those companies to seek drugs that extend their monopoly through the patent system often with insufficient benefit for consumers. The prices for those drugs are then protected from new competition. She also argues that the pharmacy benefit management system allows drug companies to exploit consumers. The conversation concludes with a discussion of what can be done to improve the situation.

1hr 5mins

8 Apr 2019

Episode artwork

December 16, 2018 - ROBIN FELDMAN (law professor) and CHRISTOPHER THORNBERG (economic forecaster)

THE BIGGER PICTURE with Timothy Spangler

Joining us on the show this week is our Special Guest - Arthur J. Goldberg Distinguished Professor of Law at UC Hastings School of Law - Robin Feldman! Robin Feldman received a bachelor's degree from Stanford University and a J.D. from Stanford Law School. Professor Feldman served in the Articles Department of the Stanford Law Review. After graduation, she clerked for The Honorable Joseph Sneed of the U.S. Court of Appeals for the Ninth Circuit. Professor Feldman has published three books, Drug Wars: How Big Pharma Raises Prices & Keeps Generics Off the Market (Cambridge 2017), Rethinking Patent Law (Harvard 2012) and The Role of Science in Law (Oxford 2009). The upcoming Drugs, Money, & Secret Handshakes: The Unstoppable Growth of Prescription Drug Prices will be released soon. She has authored more than 50 articles in including at Harvard, Yale, and Stanford, in the New England Journal of Medicine, and in the American Economic Review. Her work has been cited extensively by the White House, numerous federal and state agencies and members of Congress. Her IP/Antitrust work was cited by parties on both sides during a recent Supreme Court case. She has appeared frequently before committees of the US House & Senate, the California legislature, and federal agencies such as the FTC, DOJ, USPTO, and the National Academy of Sciences. She participated in the GAO's report to Congress on Artificial Intelligence and in the Army Cyber Institute's threatcasting exercise on weaponization of data.Also joining us on the show this week is our Special Guest - economic advisor and forecaster - Christopher Thornberg, Ph.D.! Christopher Thornberg is founding partner of Beacon Economics, LLC, and one of the nation's leading economists - with expertise in regional economics, labor markets, economic policy, and industry and real estate analysis. Dr. Thornberg famously predicted the sub-prime mortgage market collapse and the global economic recession of 2008. In 2015, he was named to California State Treasurer John Chiang's Council of Economic Advisors, the body that advises the Treasurer on emerging strengths and vulnerabilities within the state's economy. Dr. Thornberg has presented to hundreds of leading business, government, and nonprofit organizations across the globe including Chevron, The New Yorker, Colliers International, the California Chamber of Commerce, City National Bank, the California State Association of Counties, State Farm Insurance, the City of Los Angeles, the California and Nevada Credit Union League, and the National Steel and Shipbuilding Company, among many others. A well-known media commentator, Dr. Thornberg has appeared on CNN and NPR and is regularly quoted in major national dailies including the Wall Street Journal and New York Times. Originally from upstate New York, Dr. Thornberg holds a Ph.D in Business Economics from The Anderson School at UCLA, and a B.S. degree in Business Administration from the State University of New York at Buffalo.

1hr 33mins

17 Dec 2018

Most Popular

Episode artwork

Why Are Prescription Drug Prices So High? With guest Robin Feldman

The Pod Complex with Rick Ungar

Why Are Prescription Drug Prices So High? Rick tries to answer the question with Robin Feldman, author of the forthcoming book Drugs, Money, & Secret Handshakes: The Unstoppable Growth of Prescription Drug Prices. Plus the Wisconsin GOP power grab. You can call in to the show any time at (833) 711-RICK. That's (833) 711-7425.

48mins

4 Dec 2018

Episode artwork

Robin Feldman on Drug Patents, Generics, and Drug Wars

EconTalk

Robin Feldman of the University of California Hastings College of Law and author of Drug Wars talks about her book with EconTalk host Russ Roberts. Feldman explores the various ways that pharmaceutical companies try to reduce competition from generic drugs. The conversation includes a discussion of the Hatch-Waxman Act and the sometimes crazy world of patent protection.

1hr 5mins

26 Jun 2017